The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Combination Therapy with Colestipol and Psyllium Mucilloid in Patients with Hyperlipidemia

J. David Spence, MD; Murray W. Huff, PhD; Paul Heidenheim, MA; Anne Viswanatha, MSc; Claudio Munoz, MD; Robert Lindsay, MD; Bernard Wolfe, BM; and Donald Mills, PhD
[+] Article, Author, and Disclosure Information

From Victoria Hospital, University Hospital, Robarts Research Institute, and the University of Western Ontario, London, Ontario, Canada. Grant Support: The Upjohn Company of Canada, Toronto, Ontario, Canada, provided colestipol (Colestid) and funding. Searle Canada, Inc., Oakville, Ontario, Canada, provided bulk psyllium mucilloid (Metamucil). Requests for Reprints: J. David Spence, MD, Robarts and Siebens-Drake Research Institutes, Stroke Prevention and Atherosclerosis Research Centre, 1400 Western Road, London N6G 2V2, Ontario, Canada. Current Author Addresses: Drs. Spence and Munoz: Robarts and Siebens-Drake Research Institutes, Stroke Prevention and Atherosclerosis Research Centre, 1400 Western Road, London N6G 2V2, Ontario, Canada. Dr. Huff: Robarts Research Institute 416, University of Western Ontario, London N6C 3Y8, Ontario, Canada. Dr. Heidenheim: Room 137, Health Services Building, Victoria Hospital, SSC, London N6A 4G5, Ontario, Canada. Dr. Viswanatha: 47-5800 Osuna NE, Albuquerque, NM 87109. Dr. Lindsay: Nephrology Division, Room 474, Victoria Hospital, 375 South Street, London N6A 4G5, Ontario, Canada. Dr. Wolfe: 5-of-16 University Hospital, London N6A 5A5, Ontario, Canada. Dr. Mills: Drug Information, Pharmacy, Victoria Hospital, 375 South Street, London N6A 4G5, Ontario, Canada. Requests for details on the quality-of-life study should be directed to Dr. Heidenheim or Dr. Lindsay at the addresses given above.

Copyright ©2004 by the American College of Physicians

Ann Intern Med. 1995;123(7):493-499. doi:10.7326/0003-4819-123-7-199510010-00003
Text Size: A A A

Objective: To test whether combining psyllium mucilloid with half the usual dose of colestipol reduces the adverse effects associated with colestipol and maintains or increases its efficacy in the treatment of hyperlipidemia. This strategy might make bile acid sequestrants, which are seldom used because they cause adverse effects such as bloating and constipation, more tolerable and less expensive.

Design: A randomized, parallel-group, double-blind, controlled trial.

Setting: An outpatient clinic in a tertiary care hospital.

Patients: 121 patients who had moderate primary hypercholesterolemia (total cholesterol level more than 6 mmol/L and less than 8 mmol/L; triglyceride level less than 3 mmol/L) after following a low-fat diet for 1 year (National Cholesterol Education Program Step Two diet).

Intervention: 5 g of cellulose placebo; 5 g of colestipol; 2.5 g of colestipol plus 2.5 g of psyllium; or 5 g of psyllium three times daily before meals for 10 weeks.

Main Outcome Measures: At baseline and at weeks 4 and 10, fasting blood lipid levels and apoprotein concentrations were measured and a quality-of-life instrument was completed.

Results: A combination of 2.5 g of psyllium and 2.5 g of colestipol was better tolerated than and as effective as either 5 g of colestipol alone or 5 g of psyllium alone. The combination therapy and colestipol alone did not differ significantly with respect to changes in individual lipid values. The ratio of total cholesterol to high-density lipoprotein cholesterol (HDL) was reduced by 18.2% (95% CI, 12.3% to 24%) with the combination therapy; by 10.6% (CI, 2.0% to 15.4%) with colestipol alone; by 6.1% (CI, 1.5% to 10.6%) with psyllium alone; and by 0.1% (CI, −4.8% to 7%) with placebo (P = 0.0002). Combination therapy reduced the ratio of total cholesterol to HDL significantly more than did colestipol alone or psyllium alone (P < 0.05).

Conclusions: These findings suggest that adding psyllium to half the usual dose of bile acid sequestrant resins maintains the efficacy and improves the tolerability of these resins.


Grahic Jump Location
Figure 1.
Change from baseline to end of week 10 in mmol/L for lipids and g/L for apolipoproteins with 95% CIs for the change.PPP

APOA1 equals apolipoprotein A-I; APOB1 equals apolipoprotein B; HDL equals high-density lipoprotein; LDL equals low-density lipoprotein; TCHOL equals total cholesterol; TRIGLY equals triglyceride; VLDL equals very-low-density lipoprotein.* < 0.05 compared with placebo; ** < 0.001 compared with placebo and < 0.05 for combination compared with colestipol (multivariate analysis of variance with post hoc Tukey HSD tests for comparisons of significant differences).

Grahic Jump Location




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.